Bairam Aida, Laflamme Nathalie, Drolet Christine, Piedboeuf Bruno, Shah Prakesh S, Kinkead Richard
Département de Pédiatrie, Université Laval, Québec, QC, Canada.
Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, Canada.
Exp Physiol. 2018 Oct;103(10):1403-1411. doi: 10.1113/EP086996. Epub 2018 Aug 5.
What is the central question of the study? Is there a sex-based difference in the incidence of apnoea of prematurity and the success or failure of caffeine therapy in preterm infants? What is the main finding and its importance? Our data show that females received fewer days of caffeine treatment than males. This was most noticeable in infants born between 26 and 27 weeks of gestational age. These results highlight the importance of considering sex in clinical and basic research investigating the pathophysiology of apnoea of prematurity.
This retrospective cohort study assessed whether sex influences the occurrence of apnoea of prematurity (AOP) in preterm infants. The analysis included a cohort of 24,387 preterm infants born between the gestational ages (GA) of 24 and 33 weeks that were admitted to tertiary neonatal care units participating in the Canadian Neonatal Network from January 2011 to December 2015. Of those, 13,983 (57%) were diagnosed with AOP. More females were diagnosed with AOP than males, but the difference in the male/female ratio was marginal (P = 0.058). The majority (89%) of infants diagnosed with AOP received caffeine (89% of males; 89% of females). By using the discontinuation of caffeine therapy as a proxy for the resolution of significant AOP, data analysis showed that females born before 33 weeks of GA stopped caffeine treatment earlier than males whether the caffeine was discontinued before 34 or 37 weeks of GA. Consequently, females had fewer days of caffeine therapy than males, especially infants born between 26 and 27 weeks (P < 0.004), 28 and 29 weeks (P < 0.03), and 32 and 33 weeks of GA (P < 0.04). Similar trends were observed when the corrected GA at discontinuation of caffeine was used. Given that AOP is indicative of an immature respiratory system, our data suggest that the maturation of the respiratory system might occur more rapidly in females than males. We conclude that sex needs to be considered in future studies on AOP.
该研究的核心问题是什么?早产婴儿呼吸暂停的发生率以及咖啡因治疗的成败是否存在基于性别的差异?主要发现及其重要性是什么?我们的数据显示,接受咖啡因治疗的天数女性少于男性。这在孕龄26至27周出生的婴儿中最为明显。这些结果凸显了在对早产呼吸暂停病理生理学进行临床和基础研究时考虑性别的重要性。
这项回顾性队列研究评估了性别是否会影响早产婴儿发生早产呼吸暂停(AOP)。分析纳入了2011年1月至2015年12月期间入住参与加拿大新生儿网络的三级新生儿重症监护病房的24387名孕龄(GA)在24至33周之间的早产婴儿队列。其中,13983名(57%)被诊断为AOP。被诊断为AOP的女性多于男性,但男女比例差异很小(P = 0.058)。大多数(89%)被诊断为AOP的婴儿接受了咖啡因治疗(男性89%;女性89%)。通过将咖啡因治疗的停止作为严重AOP缓解的指标,数据分析显示,无论咖啡因在孕龄34周或37周之前停止,孕龄33周之前出生的女性比男性更早停止咖啡因治疗。因此,女性接受咖啡因治疗的天数少于男性,尤其是孕龄在26至27周(P < 0.004)、28至29周(P < 0.03)以及32至33周(P < 0.04)出生的婴儿。当使用停止咖啡因治疗时的校正孕龄时,也观察到了类似趋势。鉴于AOP表明呼吸系统不成熟,我们的数据表明女性呼吸系统的成熟可能比男性更快。我们得出结论,在未来关于AOP的研究中需要考虑性别因素。